Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis - Test2 - elhamkhani - TriplyDB

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

http://www.wikidata.org/entity/Q24681662

about

Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis The biological functions of T helper 17 cell effector cytokines in inflammation The T-cell pool is anergized in patients with multiple sclerosis in remission The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis Involvement of CD8(+) T Cells in Multiple Sclerosis The Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple Sclerosis The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS)Change of paradigm: CD8+ T cells as important helper for CD4+ T cells during asthma and autoimmune encephalomyelitis A role for Th17 cells in the regulation of tertiary lymphoid follicles Stage-specific immune dysregulation in multiple sclerosis Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders Diversity of IL-17-producing T lymphocytes Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis Multiple sclerosis: the role of cytokines in pathogenesis and in therapies Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond Immune Components of Liver Damage Associated with Connective Tissue Diseases Fingolimod for the treatment of neurological diseases-state of play and future perspectives Is Multiple Sclerosis an Autoimmune Disease?Immunomodulatory Effects Mediated by Dopamine NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications Environmental factors in autoimmune diseases and their role in multiple sclerosis No quiet surrender: molecular guardians in multiple sclerosis brain Multiple Sclerosis and T Lymphocytes: An Entangled Story Plasma biomarkers discriminate clinical forms of multiple sclerosis Astrocytes in multiple sclerosis: a product of their environment The IL-17 pathway as a major therapeutic target in autoimmune diseases Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis Amelioration of experimental autoimmune encephalomyelitis by anatabine MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis An approach to control relapse of inflammatory lesions after discontinuation of primary therapy Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns Circulating immune cells in multiple sclerosis.

P2860

Q22252578-C896222D-3292-4BC6-9D97-4A28EBDBE43A Q22299388-9CF56990-67E1-43B6-B0E0-CA5EEB02BC2F Q24614431-B8EBC29F-5FB2-498B-99D2-8ECC798E5CAA Q24643433-DC7F2878-726B-4302-8AD7-F2589F677837 Q24648890-0E33576F-B758-422A-B707-DE2B1B0B7286 Q26745562-9D01B571-8A96-475C-9B49-115BB1999EE0 Q26768649-A1066C81-683B-4FEC-A258-3031C914C6AF Q26771957-B02E1AF5-6419-4F48-BF61-CB2053A2C533 Q26772339-7F811B69-CEAF-46C8-BE86-A94EAF236537 Q26774642-47094201-92FB-49F8-B088-F3C306B3D87E Q26777944-B44D4C98-FAE4-4251-98A4-D6C88E085285 Q26823691-F5FB704D-E218-4641-A032-88E85B584E68 Q26824572-8C922EB8-CCB1-4469-91E7-493AD850F38B Q26851559-B17856C6-B639-4E40-82E7-24B8F39A65FC Q26852859-3587BDAE-B6ED-4F35-9A6C-E8EF3BB20701 Q26997105-BFDCD72A-E5AD-446F-A275-1145E1493A78 Q27010199-862D86A6-9357-4EC8-B0AC-E1C0748FA6EB Q27010613-120D72C2-CA7A-4DB7-8ABD-7B40649190D4 Q27011014-06D4CB5C-12B8-464F-BC7C-CE434D4786E7 Q27011857-FA88CC2F-3698-4098-8928-218F77444707 Q27015533-56375B71-9CF8-4318-A348-CB6C05C9B56D Q27026175-85C74BC8-9A64-413B-ADA2-3A386B9D4983 Q27496011-F341D394-7E07-44C7-BBA6-879F137BAFE2 Q28071580-6132777C-2E2A-4E3B-AB3D-6636033B942B Q28078299-CA22A5C2-B1DE-4459-A0C8-5D1CF29B29D9 Q28078461-12D0EAF0-2844-4952-ADFB-908BE1A3AA44 Q28084633-461D10ED-4B9F-4912-991C-083FA60E988B Q28086853-632229AF-A5FB-4B37-AF4A-5E6780C01F1D Q28262774-08450F0B-853B-4F9F-927B-B63103997151 Q28282324-4491BE42-509A-4D0A-8CCE-743240F0899D Q28300826-91C8894E-2490-4255-8A5A-C779255DCFEE Q28395248-60A01B38-9857-47CE-A98E-271678473CE6 Q28475567-3B6A95B6-F2F0-4E7D-A008-F87878D8E482 Q28485371-1977B426-973D-456A-AE0F-4CEC86711AD8 Q28509195-24192815-8044-4058-A01A-A684FB632A90 Q28538993-7EAF7757-D672-433C-AF32-324DCE184F84 Q28565232-AE3AB039-4625-439C-BF18-B3E044F034FA Q28975627-7A353D04-67A5-465C-8175-54C1244D18FB Q29391765-5522726D-F1A1-493A-8525-92FEA11F519B Q30242026-D7499C25-0BEA-432C-95C1-75D14D90EC98

P2860

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

http://www.wikidata.org/entity/Q24681662

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Interleukin-17 production in c ...... disease in multiple sclerosis

@ast

Interleukin-17 production in c ...... disease in multiple sclerosis

@en

Interleukin-17 production in c ...... disease in multiple sclerosis

@nl

type

label

Interleukin-17 production in c ...... disease in multiple sclerosis

@ast

Interleukin-17 production in c ...... disease in multiple sclerosis

@en

Interleukin-17 production in c ...... disease in multiple sclerosis

@nl

prefLabel

Interleukin-17 production in c ...... disease in multiple sclerosis

@ast

Interleukin-17 production in c ...... disease in multiple sclerosis

@en

Interleukin-17 production in c ...... disease in multiple sclerosis

@nl

P1433

Q24681662-B16E35BE-AE19-4A92-9B66-A4F365EB08F9

P1476

Q24681662-5402C1C4-0C54-454C-958D-8B565E7AC907

P2093

Q24681662-17D804AF-1659-4F71-967F-5A7EA5EC55F7

Q24681662-4E73C9D4-6441-41ED-8A03-077581C9A07C

Q24681662-61861709-8F3F-4B43-8344-8E93AA7D7AF2

Q24681662-6A56EF36-F4FC-4072-BA3F-A1B0BA88DB5E

Q24681662-FB08BFAC-9213-49BC-A494-220E2B59E5F6

P2860

Q24681662-048D9879-DE16-44BB-9A49-220764D93B82

Q24681662-0838CD92-1F42-458B-9FBD-DDA2F91DF751

Q24681662-09530B42-6C59-4D27-AAB5-4B1BA57DEFA6

Q24681662-123B5218-E108-4618-80A1-07C6E6677200

Q24681662-1A4279E5-C6C7-483B-81B1-9177E7AEDE2B

Q24681662-1D017711-42EC-4008-A417-8A697B74DA54

Q24681662-1F77EA88-47AB-4AEC-9BEF-89AAF56006A7

Q24681662-29AA3DB6-8847-4007-A7AF-4593A9F0737B

Q24681662-2A0D7A19-0500-42DD-B985-7D05518D7D75

Q24681662-37FFEE40-632E-4AFC-B167-EE4D4EFF15C1

P304

Q24681662-BD33FB71-4358-4E46-A51E-8E2E45F7BC89

P31

Q24681662-432EE224-EF0D-4EA6-A6E6-3147ABF02FCD

P3181

Q24681662-C648E907-6AEB-44AD-9046-DDF40D975FEE

P356

Q24681662-A7D475E9-32F0-4610-84A3-DF77FF571781

P407

Q24681662-03231E9F-C3CC-4CF0-A9B6-6CE096A842CA

P433

Q24681662-1EDE581A-25F7-4B4C-B481-7ED0CB87EE8B

P478

Q24681662-50F898C0-2E38-4633-81C9-E9F76E0C1B88

P50

Q24681662-88C443B6-80D8-4036-BA51-D766DB5C0905

Q24681662-9F157FF5-65AD-48D4-8105-207E46A3F60D

P577

Q24681662-E2EB1AF5-C8DA-4AAB-8792-073970AC4610

P5875

Q24681662-BE7FAD24-2F9C-46DB-A74E-CECE2DEBF4C4

P698

Q24681662-FD9F0D5B-1388-4EDC-A7C3-D41C5589BB87

P921

Q24681662-1E4B94A6-07D2-4E0C-82BA-33F68EA25FF4

Q24681662-32b047db-f1a8-458d-aaa9-65342621dace

P932

Q24681662-AF01A5BD-34CA-4462-90A9-A1C2632712A6

P3181

P356

AJPATH.2008.070690

P1433

The American Journal of Pathology

P1476

Interleukin-17 production in c ...... disease in multiple sclerosis

@en

P2093

Jackie Palace

http://www.w3.org/2001/XMLSchema#string

Jia Newcombe

http://www.w3.org/2001/XMLSchema#string

John S Tzartos

http://www.w3.org/2001/XMLSchema#string

Margaret M Esiri

http://www.w3.org/2001/XMLSchema#string

Matthew J Craner

http://www.w3.org/2001/XMLSchema#string

P2860

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

Development, cytokine profile and function of human interleukin 17-producing helper T cells

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

P304

146-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

559002

http://www.w3.org/2001/XMLSchema#string

P356

10.2353/AJPATH.2008.070690

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

Manuel A. Friese

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5693432

http://www.w3.org/2001/XMLSchema#string

P698

18156204

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

2189615

http://www.w3.org/2001/XMLSchema#string